JNJ
2024Q3BMOJohnson & Johnson primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS2.21
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move1.6%
IV front—
P/C full—
P/C front—
Features as of2024-10-14
Run-up
Close—
Ret 5d+1.3%
Ret 10d-0.3%
Ret 20d-3.2%
Ret 30d-2.6%
Actual EPS
2.42Beat
Estimated EPS2.21
Actual revenue
22.5B
Surprise %+9.5%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction+2.6%
Implied vs actual
Implied 1.6%Actual 1.0%
Gap reaction-1.0%
Day result+1.5%
Next-day upYes
Realized / IV0.62×
Post tape
Post 5d-0.4%
Post 10d-2.4%
Post volume10.5M
Vol ×10d2.10×
Vol ×20d1.87×
Post range4.8%